Skip to main content
. 2021 Jul 3;21:767. doi: 10.1186/s12885-021-08536-7

Fig. 1.

Fig. 1

Relationship between immune score and colon cancer prognosis and staging. A, B, C Kaplan-Meier Survival curves for colon cancer patients with high and low StromalScores (ImmuneScore, ESTIMATEScore). The median of the survival times for both groups was compared using a log-rank test with p values of 0.604 (0.816, 0.572, respectively). D Distribution of StromalScore in stage and TMN. The p values were all greater than 0.05, according to a Kruskal-Wallis rank sum test. E The distributed patterns of immune cells in colorectal cancer were significantly different between stage I vs IV and stage II vs IV with p values of 0.011 and 0.0031, respectively. The distribution of immune cells was different between pM0 vs pM1 (p = 0.0029), but no difference between the pT1–4 and pN0–2 stages was observed when using a Kruskal-Wallis rank-sum test. F Distribution of ESTIMATEScore in stage and TMN. The p values were all greater then 0.05, according to a Kruskal-Wallis rank sum test